865 related articles for article (PubMed ID: 9028941)
21. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
[TBL] [Abstract][Full Text] [Related]
22. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
Blood; 1995 Apr; 85(7):1936-43. PubMed ID: 7535595
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood.
Roecklein BA; Reems J; Rowley S; Torok-Storb B
Biol Blood Marrow Transplant; 1998; 4(2):61-8. PubMed ID: 9763108
[TBL] [Abstract][Full Text] [Related]
24. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
Koller MR; Palsson MA; Manchel I; Palsson BO
Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
[TBL] [Abstract][Full Text] [Related]
25. Modified in vitro conditions for cord blood-derived long-term culture-initiating cells.
Podestà M; Piaggio G; Pitto A; Zocchi E; Soracco M; Frassoni F; Luchetti S; Painelli E; Bacigalupo A
Exp Hematol; 2001 Mar; 29(3):309-14. PubMed ID: 11274758
[TBL] [Abstract][Full Text] [Related]
26. Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy: a comparison with steady-state bone marrow and peripheral blood.
Benboubker L; Binet C; Cartron G; Bernard MC; Clement N; Delain M; Degenne M; Desbois I; Colombat P; Domenech J
Exp Hematol; 2002 Jan; 30(1):74-81. PubMed ID: 11823040
[TBL] [Abstract][Full Text] [Related]
27. Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle.
Rosti V; Malabarba L; Ramajoli I; Casula S; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Salvaneschi L; Cazzola M
Haematologica; 2000 Nov; 85(11 Suppl):18-25. PubMed ID: 11268318
[TBL] [Abstract][Full Text] [Related]
28. Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor.
Pierelli L; Scambia G; Menichella G; Fattorossi A; Ciarli M; Bonanno G; Battaglia A; d'Onofrio G; Benedetti Panici P; Iacone A; Mancuso S; Leone G
Br J Haematol; 1997 Jan; 96(1):55-63. PubMed ID: 9012687
[TBL] [Abstract][Full Text] [Related]
29. The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfraction.
Croockewit AJ; Raymakers RA; Smeets ME; vd Bosch G; Pennings AH; de Witte TJ
Leukemia; 1998 Apr; 12(4):571-7. PubMed ID: 9557616
[TBL] [Abstract][Full Text] [Related]
30. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
[TBL] [Abstract][Full Text] [Related]
31. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
[TBL] [Abstract][Full Text] [Related]
32. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T
Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643
[TBL] [Abstract][Full Text] [Related]
33. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
34. Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein.
Sonoda Y; Kimura T; Sakabe H; Tanimukai S; Ohmizono Y; Nakagawa S; Yokota S; Lyman SD; Abe T
Eur J Haematol; 1997 Apr; 58(4):257-64. PubMed ID: 9186537
[TBL] [Abstract][Full Text] [Related]
35. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
[TBL] [Abstract][Full Text] [Related]
36. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
37. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
38. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
Teofili L; Iovino MS; Di Mario A; Ortu La Barbera E; Pierelli L; Bussa S; Rumi C; Menichella G; Leone G
Int J Artif Organs; 1993 Dec; 16 Suppl 5():89-95. PubMed ID: 7516922
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
Lemoli RM; Fortuna A; Tafuri A; Fogli M; Amabile M; Grande A; Ricciardi MR; Petrucci MT; Bonsi L; Bagnara G; Visani G; Martinelli G; Ferrari S; Tura S
Blood; 1996 May; 87(9):3852-9. PubMed ID: 8611712
[TBL] [Abstract][Full Text] [Related]
40. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
Kobari L; Giarratana MC; Poloni A; Firat H; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
